CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2020; 24(01): e18-e23
DOI: 10.1055/s-0039-1697989
Original Research
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Recurrence of Cholesteatoma - A Retrospective Study Including 1,006 Patients for More than 33 Years

1   Department of Ear, Nose and Throat Head and Neck Surgery, Zealand University Hospital, Køge, Denmark
,
Christina Nygaard Pedersen
3   Department of Ear, Nose and Throat Head and Neck Surgery, Odense University Hospital, Odense, Denmark
,
Line R. Grosfjeld
3   Department of Ear, Nose and Throat Head and Neck Surgery, Odense University Hospital, Odense, Denmark
,
Christian E. Faber
3   Department of Ear, Nose and Throat Head and Neck Surgery, Odense University Hospital, Odense, Denmark
,
Bjarki D. Djurhuus
1   Department of Ear, Nose and Throat Head and Neck Surgery, Zealand University Hospital, Køge, Denmark
2   Epidemiology, Biostatistics and Biodemography, Institute of Public Health, University of Southern Denmark, Odense, Denmark
› Author Affiliations
Source of Financial Support The Hans Skouby Foundation.
Further Information

Publication History

11 February 2019

27 July 2019

Publication Date:
20 December 2019 (online)

Abstract

Introduction Cholesteatomas are benign tumors consisting of skin, and growing inside a retraction pocket in the tympanic membrane. Cholesteatomas can occupy the entirety of the middle ear, and are known for their osteolytic capabilities. Surgery is the only curative treatment for cholesteatomas.

Objective To describe the risk of recurrence after first-time surgically-treated middle-ear cholesteatoma (STMEC1) on the island of Funen from 1983 to 2015.

Methods Cases of STMEC1 were identified in the Danish National Hospital Register. The medical records were reviewed. Time-to-event analyses were applied. The ears were followed from STMEC1 to a secondary cholesteatoma, emigration, death, or end of follow-up.

Results Records from 1,006 patients with STMEC1 were reviewed. A total of 54 patients were submitted to surgery on both ears. The total sample consisted of 1,060 ears with STMEC1; 300 were children's (< 16 years) ears, and 760 were adult's ears. The total observation time was of 12,049 years.

The overall estimated proportion with recurrence 5 years after surgery was of 37% in children and of 15% in adults. The older the child was at the first surgery, the risk decreased by 7% per year. In children, canal wall up (CWU) mastoidectomy without obliteration was associated with a hazard ratio for recurrence of 1.9 (95% confidence interval [95%CI]: 1.2–3.0) compared with CWU with obliteration.

Conclusion Compared with adults, children were had 2.6 times more risk of recurrence. Procedures performed without mastoidectomy had the lowest risk of recurrence. In children, obliteration was associated with a significantly lower risk of recurrence. However, patients were not randomized regarding the surgical approach; thus, the association between approach and risk of recurrence was likely influenced by confounding factors.

 
  • References

  • 1 Sie KC. Cholesteatoma in children. Pediatr Clin North Am 1996; 43 (06) 1245-1252
  • 2 van der Toom HFE, van der Schroeff MP, Pauw RJ. Single-Stage Mastoid Obliteration in Cholesteatoma Surgery and Recurrent and Residual Disease Rates: A Systematic Review. JAMA Otolaryngol Head Neck Surg 2018; 144 (05) 440-446
  • 3 Tomlin J, Chang D, McCutcheon B, Harris J. Surgical technique and recurrence in cholesteatoma: a meta-analysis. Audiol Neurotol 2013; 18 (03) 135-142
  • 4 Thygesen LC, Daasnes C, Thaulow I, Brønnum-Hansen H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 2011; 39 (7, Suppl) 12-16
  • 5 Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39 (7, Suppl) 22-25
  • 6 McGuire JK, Wasl H, Harris T, Copley GJ, Fagan JJ. Management of pediatric cholesteatoma based on presentations, complications, and outcomes. Int J Pediatr Otorhinolaryngol 2016; 80: 69-73
  • 7 Sanna M, Zini C, Gamoletti R. , et al. The surgical management of childhood cholesteatoma. J Laryngol Otol 1987; 101 (12) 1221-1226
  • 8 Darrouzet V, Duclos JY, Portmann D, Bebear JP. Preference for the closed technique in the management of cholesteatoma of the middle ear in children: a retrospective study of 215 consecutive patients treated over 10 years. Am J Otol 2000; 21 (04) 474-481
  • 9 Bylander A, Tjernström O. Changes in Eustachian tube function with age in children with normal ears. A longitudinal study. Acta Otolaryngol 1983; 96 (5-6): 467-477
  • 10 Sadler-Kimes D, Siegel MI, Todhunter JS. Age-related morphologic differences in the components of the eustachian tube/middle ear system. Ann Otol Rhinol Laryngol 1989; 98 (11) 854-858
  • 11 Gantz BJ, Wilkinson EP, Hansen MR. Canal wall reconstruction tympanomastoidectomy with mastoid obliteration. Laryngoscope 2005; 115 (10) 1734-1740
  • 12 Mercke U. The cholesteatomatous ear one year after surgery with obliteration technique. Am J Otol 1987; 8 (06) 534-536
  • 13 van Dinther JJS, Vercruysse J-P, Camp S. , et al. The Bony Obliteration Tympanoplasty in Pediatric Cholesteatoma: Long-term Safety and Hygienic Results. Otol Neurotol 2015; 36 (09) 1504-1509
  • 14 Vercruysse J-P, De Foer B, Somers T, Casselman JW, Offeciers E. Mastoid and epitympanic bony obliteration in pediatric cholesteatoma. Otol Neurotol 2008; 29 (07) 953-960
  • 15 Lee WS, Choi JY, Song MH, Son EJ, Jung SH, Kim SH. Mastoid and epitympanic obliteration in canal wall up mastoidectomy for prevention of retraction pocket. Otol Neurotol 2005; 26 (06) 1107-1111
  • 16 Djurhuus BD, Skytthe A, Faber CE. Validation of the cholesteatoma diagnosis in the Danish National Hospital Register. Dan Med Bull 2010; 57 (10) A4159
  • 17 Djurhuus BD, Skytthe A, Christensen K, Faber CE. Cholesteatoma in Danish children - a national study of changes in the incidence rate over 34 years. Int J Pediatr Otorhinolaryngol 2015; 79 (02) 127-130